Silexion Therapeutics Corp (SLXN) Description, Stock price, News & Info.

#ThinkSabio Latest News

Silexion Therapeutics to Present SIL-204 Data in KRAS-Driven Pancreatic Cancer at the 2025 ASCO Gastrointestinal Cancers Symposium

Leave a Reply

Your email address will not be published. Required fields are marked *